International Journal for Parasitology: Drugs and Drug Resistance

SJR Rank #6,946H-index: 59SJR: 0.797Best quartile: Q1Open AccessAPC: US$2,700Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Elsevier Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • ParasitologyQ1
  • Infectious DiseasesQ2
  • PharmacologyQ2
  • Pharmacology (medical)Q2

Areas: Immunology and Microbiology · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Helminth infection and controlParasites and Host InteractionsParasite Biology and Host InteractionsResearch on Leishmaniasis StudiesMalaria Research and ControlTrypanosoma species research and implicationsParasitic Infections and DiagnosticsCoccidia and coccidiosis researchMosquito-borne diseases and controlParasitic Diseases Research and Treatment

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs03570105140

Documents per Year

20222025015304560

Detailed Information

ISSN

2211-3207

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

3.98

References per Document

66.68

Coverage

2011-2026

Scope

The International Journal for Parasitology – Drugs and Drug Resistance is one of a series of specialist, open access journals launched by the International Journal for Parasitology. It publishes the results of original research in the area of anti-parasite drug identification, development and evaluation, and parasite drug resistance. The journal also covers research into natural products as anti-parasitic agents, and bioactive parasite products. Studies can be aimed at unicellular or multicellular parasites of human or veterinary importance.

Metrics from SCImago Journal Rank 2025. View on SCImago